{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:28:40Z","timestamp":1789986520858,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.schres.2022.08.024","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T12:31:53Z","timestamp":1663504313000},"page":"292-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The validity of atypical psychosis diagnostic criteria to detect anti-NMDA receptor encephalitis with psychiatric symptoms"],"prefix":"10.1016","volume":"248","author":[{"given":"Kenji","family":"Hinotsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Miyaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Yada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Okahisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kanbayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soshi","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Takaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2022.08.024_bb0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1176\/ajp.134.1.78","article-title":"Catatonia: prediction of response to somatic treatments","volume":"134","author":"Abrams","year":"1977","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.08.024_bb0010","first-page":"111","article-title":"Catatonia and mania: patterns of cerebral dysfunction","volume":"4","author":"Abrams","year":"1979","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2022.08.024_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","article-title":"The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data","volume":"6","author":"Al-Diwani","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2022.08.024_bb0020","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/epi.12127","article-title":"Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy","volume":"54","author":"Brenner","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.schres.2022.08.024_bb0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.schres.2017.03.012","article-title":"Seroprevalence survey of selective anti-neuronal autoantibodies in patients with first-episode schizophrenia and chronic schizophrenia","volume":"190","author":"Chen","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.08.024_bb0030","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.schres.2022.08.024_bb0035","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.schres.2022.08.024_bb0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0896-6273(00)80715-1","article-title":"Activation of Heschl's gyrus during auditory hallucinations","volume":"22","author":"Dierks","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.schres.2022.08.024_bb0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","article-title":"Neurological autoantibody prevalence in epilepsy of unknown etiology","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.schres.2022.08.024_bb0050","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/acps.12963","article-title":"Frequency of neuropsychiatric disturbances in anti-NMDA receptor encephalitis","volume":"138","author":"Espinola-Nadurille","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2022.08.024_bb0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0733-8619(05)70368-6","article-title":"Complications of lumbar puncture","volume":"16","author":"Evans","year":"1998","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.schres.2022.08.024_bb0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.seizure.2018.12.015","article-title":"EEG findings in NMDA encephalitis - a systematic review","volume":"65","author":"Gillinder","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.schres.2022.08.024_bb0065","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.schres.2022.08.024_bb0070","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.schres.2022.08.024_bb0075","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1212\/WNL.0000000000012191","article-title":"Clinical, neuroimmunologic, and CSF investigations in first episode psychosis","volume":"97","author":"Guasp","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.schres.2022.08.024_bb0080","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/mp.2013.110","article-title":"Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity","volume":"19","author":"Hammer","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2022.08.024_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1819.1996.tb01656.x","article-title":"The concept of \u2018atypical psychoses\u2019: special reference to its development in Japan","volume":"50","author":"Hatotani","year":"1996","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2022.08.024_bb0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fpsyt.2017.00025","article-title":"Red flags: clinical signs for identifying autoimmune encephalitis in psychiatric patients","volume":"8","author":"Herken","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.schres.2022.08.024_bb0095","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ajmg.b.32164","article-title":"Genome-wide association study of atypical psychosis","volume":"162B","author":"Kanazawa","year":"2013","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.schres.2022.08.024_bb0100","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.euroneuro.2019.07.137","article-title":"Anti-NMDA-receptor antibody in initial diagnosis of mood disorder","volume":"29","author":"Kawai","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2022.08.024_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/157340011797183184","article-title":"Anti-NMDA receptor encephalitis in psychiatry","volume":"7","author":"Kayser","year":"2011","journal-title":"Curr. Psychiatry Rev."},{"key":"10.1016\/j.schres.2022.08.024_bb0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/schbul\/sbq087","article-title":"Catatonic schizophrenia: a cohort prospective study","volume":"38","author":"Kleinhaus","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.08.024_bb0115","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000280","article-title":"Neuroleptic intolerance in patients with anti-NMDAR encephalitis","volume":"3","author":"Lejuste","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.schres.2022.08.024_bb0120","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.eplepsyres.2013.12.015","article-title":"Lack of antibodies to NMDAR or VGKC-complex in GAD and cardiolipin antibody-positive refractory epilepsy","volume":"108","author":"Liimatainen","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.schres.2022.08.024_bb0125","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00221-017-4917-4","article-title":"How do the two visual streams interact with each other?","volume":"235","author":"Milner","year":"2017","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.schres.2022.08.024_bb0130","first-page":"23","article-title":"Concept of atypical psychosis\u2013from the aspect of clinical genetics","volume":"64","author":"Mitsuda","year":"1962","journal-title":"Seishin Shinkeigaku Zasshi"},{"key":"10.1016\/j.schres.2022.08.024_bb0135","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0447.1965.tb04996.x","article-title":"The concept of \"atypical psychoses\" from the aspect of clinical genetics","volume":"41","author":"Mitsuda","year":"1965","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2022.08.024_bb0140","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archneurol.2009.5","article-title":"Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy","volume":"66","author":"Niehusmann","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.schres.2022.08.024_bb0145","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00213-021-06036-x","article-title":"Impairment of early neuronal maturation in anti-NMDA-receptor encephalitis","volume":"239","author":"Okamoto","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2022.08.024_bb0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41398-018-0272-x","article-title":"Next-generation sequencing analysis of multiplex families with atypical psychosis","volume":"8","author":"Okayama","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2022.08.024_bb0155","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1017\/S003329171300295X","article-title":"Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis","volume":"44","author":"Pollak","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2022.08.024_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin","volume":"7","author":"Pollak","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2022.08.024_bb0165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.psym.2015.11.007","article-title":"Epileptic catatonia: a case series and systematic review","volume":"57","author":"Repchak","year":"2016","journal-title":"Psychosomatics"},{"key":"10.1016\/j.schres.2022.08.024_bb0170","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S2215-0366(19)30190-7","article-title":"Catatonia and the immune system: a review","volume":"6","author":"Rogers","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2022.08.024_bb0175","first-page":"189","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis in psychiatry","volume":"73","author":"Sakamoto","year":"2019","journal-title":"Acta Med. Okayama"},{"key":"10.1016\/j.schres.2022.08.024_bb0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/JCP.0000000000000439","article-title":"Anti-inflammatory therapy and immunotherapy were partially effective in a patient with anti-N-methyl-D-aspartate receptor antibodies and a special subgroup of treatment-resistant schizophrenia","volume":"36","author":"Senda","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2022.08.024_bb0185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bja.2021.03.028","article-title":"Current status of perioperative hypnotics, role of benzodiazepines, and the case for remimazolam: a narrative review","volume":"127","author":"Sneyd","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.schres.2022.08.024_bb0190","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/schbul\/sbx059","article-title":"Limbic interference during social action planning in schizophrenia","volume":"44","author":"Stegmayer","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.08.024_bb0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","article-title":"Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis","volume":"70","author":"Steiner","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2022.08.024_bb0200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.schres.2013.04.034","article-title":"Catatonia in DSM-5","volume":"150","author":"Tandon","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.08.024_bb0205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.schres.2022.08.024_bb0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-244X-12-37","article-title":"Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features","volume":"12","author":"Tsutsui","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2022.08.024_bb0215","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S2215-0366(18)30474-7","article-title":"Structure and neural mechanisms of catatonia","volume":"6","author":"Walther","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2022.08.024_bb0220","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000480514","article-title":"Comparisons between psychiatric symptoms of patients with anti-NMDAR encephalitis and new-onset psychiatric patients","volume":"75","author":"Wang","year":"2017","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.schres.2022.08.024_bb0225","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/acps.12941","article-title":"Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis","volume":"138","author":"Warren","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2022.08.024_bb0230","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.brs.2018.11.016","article-title":"Electroconvulsive therapy for anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: a systematic review of cases","volume":"12","author":"Warren","year":"2019","journal-title":"Brain Stimul."},{"key":"10.1016\/j.schres.2022.08.024_bb0235","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/epi.13356","article-title":"Neuronal antibodies in pediatric epilepsy: clinical features and long-term outcomes of a historical cohort not treated with immunotherapy","volume":"57","author":"Wright","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.schres.2022.08.024_bb0240","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1176\/appi.neuropsych.16050101","article-title":"Anti-NMDA receptor antibody positivity and presentations without seizure, involuntary movement, hypoventilation, or tumor: a systematic review of the literature","volume":"29","author":"Yoshimura","year":"2017","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2022.08.024_bb0245","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13033-021-00505-8","article-title":"Assessment of catatonia and inter-rater reliability of three instruments: a descriptive study","volume":"15","author":"Zingela","year":"2021","journal-title":"Int. J. Ment. Health Syst."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422003309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422003309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:52:35Z","timestamp":1760298755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996422003309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":49,"alternative-id":["S0920996422003309"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2022.08.024","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The validity of atypical psychosis diagnostic criteria to detect anti-NMDA receptor encephalitis with psychiatric symptoms","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2022.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}